Application and efficacy of quetiapine in patients with high-risk factors for bipolar disorder: A randomized controlled trial
Combination of quetiapine and sertraline can more rapidly alleviate anxiety and depressive symptoms in patients with AD at high-risk factors for BD, improving treatment outcomes.
Authors
- Lei Zeng (ORCID: https://orcid.org/0000-0001-6517-8772)
- Fang Yu (ORCID: https://orcid.org/0000-0002-9399-1987)
- Chenjie Ge (ORCID: https://orcid.org/0000-0002-3521-8021)
- Lianlian Lei (ORCID: https://orcid.org/0000-0003-0463-2614)
- Mincai Qian
- Hong Wang (ORCID: https://orcid.org/0000-0001-5700-6786)
- Shiliang Wang (ORCID: https://orcid.org/0009-0002-9564-1793)
Institutions
- Third People's Hospital of Huzhou (CN)
Publication Details
- Journal
- World Journal of Psychiatry
- Published
- 2025-08-08
- DOI
- https://doi.org/10.5498/wjp.v15.i8.104221
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00